MEGHAN SOWERS: Open Payments
NPI 1477228369 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,831 in 64 payments from 19 companies in 2025. Trend: 2023 $1,754 · 2024 $10,616 · 2025 $3,831
Food & beverage: $2,576Travel & lodging: $1,175Education: $80
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 12 | $1,709 |
| Syndax Pharmaceuticals, Inc. | 9 | $535 |
| Astellas Pharma US Inc | 7 | $271 |
| Novartis Pharmaceuticals Corporation | 6 | $184 |
| Lilly USA, LLC | 3 | $162 |
| Adaptive Biotechnologies Corporation | 1 | $154 |
| PFIZER INC. | 2 | $152 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| Celgene Corporation | 3 | $88 |
| PharmaEssentia USA Corporation | 2 | $59 |
Products named: Jakafi, SCEMBLIX, JAYPIRCA, clonoSEQ, Cresemba, ADCETRIS, REBLOZYL, CALQUENCE.
Industry payments across TX — which companies pay providers there.
